Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer

Although multigene panel testing is increasingly common in patients with cancer, the relationship between its use among breast cancer patients with non‐BRCA mutations or variants of uncertain significance (VUS) and disease management decisions has not been well described. This study evaluated the ra...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cancer Med
Главные авторы: Elsayegh, Nisreen, Webster, Rachel D., Gutierrez Barrera, Angelica M., Lin, Heather, Kuerer, Henry M., Litton, Jennifer K., Bedrosian, Isabelle, Arun, Banu K.
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2018
Предметы:
Cancer Prevention
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6010764/
https://ncbi.nlm.nih.gov/pubmed/29733510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1519
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы